Medical Device News Magazine

The CHIRON Group Acquires HSTEC

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The CHIRON Group, headquartered in Tuttlingen, Germany, is continuing to follow its global growth strategy in 2022 too, and today announced its takeover of 90 percent of the Croatian company HSTEC.

The name HSTEC stands for »high speed technique«, for system expertise in development, design and manufacture of high-speed motor spindles for challenging machining. Clamping devices for machining centers and automation solutions complete the portfolio. Furthermore, HSTEC is leading the way in spindle services and repair for in-house products and spindles from other manufacturers.

With the acquisition, the CHIRON Group is expanding its capacities and strengthening three areas of expertise: Complete development, manufacturing and assembly of the key components, motor spindles and turning spindles, for the Group’s machining centers. With HSTEC fixtures for workpiece clamping, turnkey projects can be designed even better in line with customer-specific specifications. Furthermore, the CHIRON Group is expanding its services globally to include part repair, refurbishing and optimizing of all motor spindles in existing machines.

With the new name CHIRON Croatia, the CHIRON Group has a presence in eastern Europe with another of its own companies; it can support customers better in the region and will continue to develop at the Zadar site. Over 100 employees, 25 of whom alone work in engineering, increase the number of employees in the Group globally to around 1,900.

The current CEO Mladen Šarlija has been appointed Managing Director of CHIRON Croatia. The representative offices of HSTEC in Germany, the USA and China will remain, as well representation of Balluff, Bosch Rexroth, Hofmann and Mitutoyo for the Croatian market.

HSTEC will continue as a brand, joining the ranks of the CHIRON Group brands: CHIRON, STAMA, FACTORY5, CMS, GREIDENWEIS, HSTEC.

Medical Device News Magazine
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

ArisGlobal Reports | Newest Version of LifeSphere® Regulatory Platform Launches

Ann-Marie Orange, CIO & Global Head of R&D shares, “With more than 35 years of experience in life sciences technology, ArisGlobal is the only technology company offering strong Safety, Regulatory, and Quality Management solutions powered with next-generation cognitive computing, delivering unmatched interoperability across the R&D IT ecosystem. Over the last 18 months ArisGlobal has made significant investment in the strategic acquisitions of Amplexor Life Sciences and SPORIFY, along with technology R&D – and we’re not stopping.”